000			01987 a2200505 4500
005			20250518041624.0
264		0	_c20190826
008			201908s 0 0 eng d
022			_a1095-6859
024	7		_a10.1016/j.ygyno.2019.05.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aLiu, Joyce F
245	0	0	_aResults from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer. _h[electronic resource]
260			_bGynecologic oncology _c07 2019
300			_a95-101 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aDiamines _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMAP Kinase Kinase Kinases _xantagonists & inhibitors
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aProgression-Free Survival
650	0	4	_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors
650	0	4	_aPyrazoles _xadministration & dosage
650	0	4	_aPyridones _xadministration & dosage
650	0	4	_aPyrimidinones _xadministration & dosage
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aUterine Cervical Neoplasms _xdrug therapy
700	1		_aGray, Kathryn P
700	1		_aWright, Alexi A
700	1		_aCampos, Susana
700	1		_aKonstantinopoulos, Panagiotis A
700	1		_aPeralta, Ariana
700	1		_aMacNeill, Kimberley
700	1		_aMorrissey, Stephanie
700	1		_aWhalen, Christin
700	1		_aDillon, Deborah
700	1		_aMatulonis, Ursula A
773	0		_tGynecologic oncology _gvol. 154 _gno. 1 _gp. 95-101
856	4	0	_uhttps://doi.org/10.1016/j.ygyno.2019.05.003 _zAvailable from publisher's website
999			_c29719087 _d29719087